-+ 0.00%
-+ 0.00%
-+ 0.00%

Fractyl Health Appoints Michael Wartell as Independent Director

PUBT·11/06/2026 21:36:17
Listen to the news
Fractyl Health Appoints Michael Wartell as Independent Director
  • Fractyl Health appointed Michael Wartell as an independent Class III director effective November 2, 2026, expanding its board from nine to 10.
  • His term expires at the 2027 annual shareholder meeting.
  • Wartell is president of Bluerose Associates, with over 35 years of investment experience and extensive public- and private-company board experience.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fractyl Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-451917), on November 06, 2026, and is solely responsible for the information contained therein.